BARD1 and breast cancer: The two studies by Dorling et al. and Hu et al. have definitely confirmed the role of BARD1 as a moderate BC susceptibility gene (OR: 2.09; 95% CI, 1.35–3.23; P = 0.00098, for protein-truncation variants4).